Anery Patel is an Endocrinology/Metabolic physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 25 publications with 252 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile 42nd St
Omaha, NE 681980001
Telephone
402-559-8700Registry record last updated 10 May 2019.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Horizon Therapeutics plcProgram year20231 payment
- AbbVie Inc.Program year202111 payments
- Lilly USA, LLCProgram year20216 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
55.3%l-Thyroxine48.3%Levothyroxine Sodium90%Synthroid11%Part D≥112 patientsThyroid Hormone Synthesis Inhibitor5.7%Methimazole100%Part D≥17 patients+ 1 more class in this area
Metabolism & gastrointestinal
30.1%GLP-1 receptor agonist13.1%Ozempic55%Trulicity35%Mounjaro10%Part D<11 patientsInsulin Analog11%Lantus Solostar32%Novolog Flexpen25%Lantus16%Humalog Kwikpen U-10016%Novolog12%Part D<11 patients+ 2 more classes in this area
Sensory organs
10.9%Corticosteroid10.9%Hydrocortisone85%Dexamethasone15%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Thyroid Surgery With Body Mass Index: a 10-Y Cohort Study
Journal of Surgical Research
2026 - Recombinant TSH Performs as Well as Thyroid Hormone Withdrawal for Iodine-131 Therapy With Dosimetry for Thyroid Cancer
Journal of the Endocrine Society
2025 - Improving Diagnostic Precision in Thyroid Pathology by Synergistic Use of AI and Molecular Markers
Graduate Medical Education Research Journal
2025 - Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
The Journal of Clinical Endocrinology & Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”